--- title: "𖣂📈 The next evolution: SCX on the ASX; A4N at overcapacity+; 4 days GTA VI for 2 years of service?" description: "HOMODEUS RESEARCH WEEKLY BRIEF · 25 August 2026 Research | Videos | Podcasts | LinkedIn | Follow on X Downstream AI Hi, Last Friday I was privileged to be invited to the SCX.ai (ASX:SCX) listing ceremony at the new ASX HQ on Martin place. The Picks and Shovels of AI have been the topic du jour for some time now, but as AI matures, downstream plays in my view will start to come into focus. SCX is a bit of both. Still very much on the hardware side, but shifting from building AI (training), to usi" canonical_url: "https://homodeus.one/research/report/the-next-evolution-scx-on-the-asx-a4n-at-overcapacity-4-days-gta-vi-for-2-years-service-weekly-2026-08-25" markdown_url: "https://homodeus.one/api/reports/the-next-evolution-scx-on-the-asx-a4n-at-overcapacity-4-days-gta-vi-for-2-years-service-weekly-2026-08-25.md" access: "full" source: "Homodeus Research" id: "4f57d645-8147-4067-9bf2-cef8d3bcab1d" report_type: "weekly" published_date: "2026-08-25" lead_analyst: "Wei Sim" requires_payment: false issuer_paid: false html_access: "free-registration" html_registration_required: true keywords: "weekly,email-campaign" modified_date: "2026-08-24T18:30:15.960Z" --- # 𖣂📈 The next evolution: SCX on the ASX; A4N at overcapacity+; 4 days GTA VI for 2 years of service? Published 2026-08-25 by Wei Sim. HOMODEUS **RESEARCH** WEEKLY BRIEF · 25 August 2026 [Research](https://homodeus.one/research) | [Videos](https://homodeus.one/research/videos) | [Podcasts](https://homodeus.one/research/podcasts) | [LinkedIn](https://www.linkedin.com/company/homodeus-research/) | [Follow on X](https://x.com/homodeus_rsrch) Downstream AI *Hi,* *Last Friday I was privileged to be invited to the ****SCX.ai (ASX:SCX)**** listing ceremony at the new ASX HQ on Martin place. The *[Picks and Shovels](https://www.investopedia.com/terms/p/pick-and-shovel-play.asp)* of AI have been the topic du jour for some time now, but as AI matures, downstream plays in my view will start to come into focus. SCX is a bit of both. Still very much on the hardware side, but shifting from building AI (training), to using AI (inference). If you’re a *[ where the puck is heading](https://en.wiktionary.org/wiki/where_the_puck_is_heading)*investor, it’s worth doing some work on ****SCX.ai (ASX:SCX)**** and ****Decidr (ASX:DAI)*** | | | | --- | --- | | Left: SCX.ai listing 1 second before open; Right: Listing party at new ASX HQ w/ David (CEO) & Rahul (CFO) | | **Idea of the week: Alpha HPA (ASX:A4N) **is a forward looking** **semi-conductor play. AI is a tailwind, but even in absence of AI, material science as the next evolution in semiconductor design will drive growth in A4N. Last week the company signed** **New** **Letter of of intent for 1,400 tonnes of HPA from Speciality South Korean ceramics end-user. *As highlighted in our *[recent research](https://homodeus.one/research/report/alpha-hpa-a4n-ax-zero-not-all-9s-are-created-equal-foundation-research)* the surge in demand is very recent, but very real. Continues to rise increase, now tracking at 32% above Stage 2 capacity* ![](https://homodeus.one/api/email/assets/2819f9da-ca4d-4081-a29f-935cab79f017) Webinars this week: | | | | --- | --- | | Alma Metals (ASX:ALM) | Complii (ASX:CF1) | **NEWS THIS WEEK** - Stuart MacDonald transitioning from Tech1 (ASX:TNE) COO to Hansen (ASX:HSN) CEO. Source: [TNE](https://announcements.asx.com.au/asxpdf/20260819/pdf/072xjgh1x9dm4h.pdf) | [HSN](https://announcements.asx.com.au/asxpdf/20260819/pdf/072xf4wvtv5grt.pdf) HD View: A great opportunity for Stu. He’s done excellent work for TNE, and if he can replicate the success he’s contributed to TNE at HSN they’ll be off to the races. TNE positive outlook remains unchanged. - Edinburgh Leisure have successfully launched their new TechOne (ASX:TNE) CAFM system. Source: [LinkedIn](https://www.linkedin.com/posts/edinburgh-leisure_edinburghleisure-technologyone-facilitiesmanagement-activity-7496188542671454208-0QS3) - 4DMedical (ASX4DX) will offer Azra AI’s real-time patient identification and care coordination platform through a strategic OEM and reseller partnership, to health system customers, helping connect incidental findings to the right care teams, imaging, follow-up, and ongoing management. Source [LinkedIn](https://www.linkedin.com/posts/4dmedical_pulmonology-radiology-lunghealth-activity-7495161379784388608-c1Kr) HD View: This was announced at the quarterly, but alongside much of their newsflow hasn’t garnered the appropriate attention given the rapid pace of developments at 4DX. ![](https://homodeus.one/api/email/assets/d78e7621-ee9d-4b5d-b32e-520a4da7b213) - Oneview (ASX:ONE) at Epic UGM 2026: Stop by to see how we're bringing Epic MyChart Bedside to life on our hardware platform, alongside Bedside TV Whiteboard. Source: [LinkedIn](https://www.linkedin.com/posts/oneviewhealthcare_chris-miller-and-i-are-excited-to-be-setting-activity-7495143368512032768-48DT) HD View: Oneview only announced its new revenue channel powering Epic MyChart Bedside TV in May this year. It’s great to see them attending UGM, showing support from Epic on the integration. - Alpha HPA (ASX:A4N) Product Marketing Update: NewLetter of of intent for 1,400 tonnes of HPA from Speciality South Korean ceramics end-user. Source: [ASX](https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-03122172-2A1690064&v=undefined) HD View: As highlighted in our recent research the surge in demand is very recent, but very real. Continues to rise increase, now tracking at 32% above Stage 2 capacity ![](https://homodeus.one/api/email/assets/9ebe057b-cbdb-42c0-b037-d9ce148a10ce) - Pro Medicus (ASX:PME) share price soars 12% on strong FY26 result: A key reason for the significant increase in statutory profit is its investment in 4DMedical (ASX: 4DX) , which has risen significantly since the start of FY26. Share price growth is added to Pro Medicus’ statutory net profit. Source: [Rask](https://www.raskmedia.com.au/2026/08/18/pro-medicus-asxpme-share-price-soars-12-on-strong-fy26-result/) - Bots are starting to conspire with one another. Can they be stopped? Let’s be very clear about what OpenAI is saying: a group of AI models colluded for months, undetected by their maker, and hacked another company. To this day, OpenAI says it is not entirely sure what went wrong or how to remediate it. Source:[AFR](https://www.afr.com/technology/bots-are-starting-to-conspire-with-one-another-can-they-be-stopped-20260818-p60pia) - FDA wants feedback on how to regulate generative AI in medicine: The U.S. Food and Drug Administration is mulling how to best regulate generative artificial intelligence in medicine and is seeking feedback from the public on the matter. Source: [Radiology Business](https://radiologybusiness.com/topics/artificial-intelligence/fda-wants-feedback-how-regulate-generative-ai-medicine) - Trump nominates policy aide Overton to lead FDA: Trump on Wednesday nominated Heidi Overton, a top White House policy aide, as the next Food and Drug Administration commissioner. Source: [Biopharm Dive](https://www.biopharmadive.com/news/overton-fda-commissioner-trump-white-house-appointment-plans/828264/) HD View: Heidi Overton is viewed as being strongly pro-innovation, faster-approval agenda which should continue to be supportive for the likes of med-tech approvals (i.e. IMR , 4DX , EIQ , AYA , PME etc) - Most FDA-cleared AI medical devices not tested on patient outcomes: Out of over 1,300 FDA-authorized AI medical devices, only three have been evaluated for their impact on patient outcomes like mortality, morbidity, or hospital readmissions. Source: [AuntMinnie](https://www.auntminnie.com/imaging-informatics/artificial-intelligence/article/15832887/most-fdacleared-ai-medical-devices-not-tested-on-patient-outcomes) HD View: this translates to a mere 0.2% being tested on patient-centred outcomes. Could this impact on AI FDA clearance going forward? Possibly. That said we do not see this as a huge risk for the likes of ASX:4DX or ASX:IMR which are replacing contrast and fluoroscopy procedures, which are clearly more detrimental to patient outcomes. - Medicare works to speed up coverage for ‘breakthrough’ radiology devices: Experts have noted there often is a lag—at a median of nearly six years—between the FDA authorizing new products and Medicare granting payment. The RAPID pathway aims to allow the two agencies to collaborate earlier in product life cycles, generating evidence to more rapidly support decisions. Source: [Radiology Business](https://radiologybusiness.com/topics/healthcare-management/healthcare-policy/medicare-works-speed-coverage-breakthrough-radiology-devices) HD View: Of the med-tech names Imricor (ASX:IMR) the largest potential beneficiary of this news on AFL, VT and AF regulatory approvals (depending on pathway). Other sw/algo names (i.e. PME, EIQ, 4DX, AYA) less so for existing solutions, but potentially future (e.g. 4DMedical’s (ASX:4DX) XV Scanner) - Mayo Clinic taps new CIO as academic medical center doubles down on AI: Bhaskara-Baba brings more than 25 years of tech experience to the role. He joins Mayo from Honeywell Aerospace and Defense, where he directed digital strategy and scaled the company’s artificial intelligence capabilities as CIO. Source: [HC Dive](https://www.healthcaredive.com/news/mayo-clinic-taps-new-cio-as-academic-medical-center-doubles-down-on-ai/828256/) - Google’s AI debt machine lands with four brokers and a video link. Fresh from reportedly attracting $US115 billion ($162 billion) in bids for new bonds 10 days ago, Google and YouTube owner Alphabet rolled into Australia for this first time this week to ask for just one thing: mo’ money. Source: [AFR](https://www.afr.com/chanticleer/google-s-ai-debt-machine-lands-with-four-brokers-and-a-video-link-20260817-p60ozy) ![](https://homodeus.one/api/email/assets/cfefdb53-fce5-4e10-82b5-62eb3ee55cf3)![](https://homodeus.one/api/email/assets/6f60708c-f0cf-4e1c-a9e6-31f93ee08117) - Why We Built SCX (ASX:SCX) — And Why We Are Listing Now. Source: [SCX.ai](https://scx.ai/resources/why-we-built-scx-listing-now) - NSW to manage data centre boom with new planning and cost measures. Both the NSW Data Centre NSW Data Centre Policy Framework and NSW Data Centre Guidelines aim to address rising electricity demand, water consumption, infrastructure funding, community impacts and the long-term role of data centres in supporting Australia’s AI and digital economy. Source: [ARN](https://www.arnnet.com.au/article/4210210/nsw-to-manage-data-centre-boom-with-new-planning-and-cost-measures.html) HD View: as we’ve mentioned in previous weeks the upcoming listing of SCX.ai (ASX:SCX) is a company directly addressing these issues with their dedicated SambaNova inferencing chips which consume 1/12th of the energy for inferencing and do not require water cooling. - Jamie Oliver partners Life360 for microdrama comedy series Source: [Jamie Oliver](https://www.jamieoliver.com/life360/) HD View: 🤣 trailer is available on [YouTube here](https://youtu.be/o733lJhFt44) ![](https://homodeus.one/api/email/assets/45409ee1-995c-4dd7-aef7-b8b96676a713) - Army unit offers 4-day pass to play Grand Theft Auto VI as reenlistment incentive. Eligible soldiers must reenlist for a minimum of two years and up to six years. Source: [CBS news](https://www.cbsnews.com/news/grand-theft-auto-army-reenlistment-bonus/) HD View: Wow! I guess if you were going to reenlist anyway, why not, but otherwise… **CALENDAR** | Date \| Time | Time | Event | Company | Details | | --- | --- | --- | --- | --- | | 26th August 2026 | 09:00 AEST | Alterity Therapeutics | ASX:ATH | Link | | 27th August 2026 | 08:00 AEST | Oneview Healthcare - HY26 Half Year Results Call | ASX:ONE | Link | | 28th August 2026 | 14:00 AEST | Data Centre Cooling Industry Expert | ASX:CRR | Link | | 3rd September 2026 | 11:00 AEST | Green & Gold Minerals | ASX:GG1 | Link | **COMPS TABLE** ![](https://homodeus.one/api/email/assets/adf8c16e-f8f3-4e86-b482-86afe9a226f4) **Wei Sim (founder) – **[Book a meeting with me](https://calendar.app.google/TQU7cNMVzPXm35c29) [+61 428 536 756](tel:+61428536756) [wei@homodeus.one](mailto:wei@homodeus.one) [X](https://x.com/Homodeus_Rsrch) | [LinkedIn](https://www.linkedin.com/company/homodeus-research/) | [homodeus.one](https://homodeus.one/) ![](https://homodeus.one/api/email/assets/7112a64c-059c-48c2-8665-0daccb38dd40) ![](https://homodeus.one/api/email/assets/2735161d-797e-4032-8d17-a440efe6f99f) This email is sent by Wei Sim on behalf of **Homodeus One Pty Ltd** (ABN 83 696 272 116), Corporate Authorised Representative (No. 1320577) of **Sharewise Compliance and Administration Pty Ltd** (ABN 11 098 020 734, AFSL 280420). Any financial product advice contained in this email is general advice only and has been prepared without considering your objectives, financial situation, or needs. You should consider the appropriateness of the advice before acting on it. Please refer to our [Financial Services Guide (FSG)](https://homodeus.one/fsg) or contact us to request a copy. This email and any attachments are confidential. If you have received this email in error, please notify the sender immediately and delete it. Any unauthorised use, dissemination, or copying is prohibited. [homodeus.one](https://homodeus.one/) ·| [Research](https://homodeus.one/research) |· [Contact](https://homodeus.one/contact) Homodeus One Pty Ltd · ABN 83 696 272 116 · CAR 1320577 · AFSL 280420 *Prepared for wholesale clients only pursuant to s761G(7) of the Corporations Act (Cth). General information only — not personal advice or a solicitation. See homodeus.one for our Privacy Policy, Terms of Use, and Financial Services Guide.* [Unsubscribe](mailto:info@homodeus.one?subject=unsubscribe) |·